Literature DB >> 10466926

Endoderm differentiation and inductive effect of activin-treated ectoderm in Xenopus.

H Ninomiya1, S Takahashi, K Tanegashima, C Yokota, M Asashima.   

Abstract

When presumptive ectoderm is treated with high concentrations of activin A, it mainly differentiates into axial mesoderm (notochord, muscle) in Xenopus and into yolk-rich endodermal cells in newt (Cynops pyrrhogaster). Xenopus ectoderm consists of multiple layers, different from the single layer of Cynops ectoderm. This multilayer structure of Xenopus ectoderm may prevent complete treatment of activin A and subsequent whole differentiation into endoderm. In the present study, therefore, Xenopus ectoderm was separated into an outer layer and an inner layer, which were individually treated with a high concentration of activin A (100 ng/mL). Then the differentiation and inductive activity of these ectodermal cells were examined in explantation and transplantation experiments. In isolation culture, ectoderm treated with activin A formed endoderm. Ectodermal and mesodermal tissues were seldom found in these explants. The activin-treated ectoderm induced axial mesoderm and neural tissues, and differentiated into endoderm when it was sandwiched between two sheets of ectoderm or was transplanted into the ventral marginal zone of other blastulae. These findings suggest that Xenopus ectoderm treated with a high concentration of activin A forms endoderm and mimics the properties of the organizer as in Cynops.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10466926     DOI: 10.1046/j.1440-169x.1999.00449.x

Source DB:  PubMed          Journal:  Dev Growth Differ        ISSN: 0012-1592            Impact factor:   2.053


  9 in total

1.  Generation of functional hepatic cells from pluripotent stem cells.

Authors:  Songyan Han; Alice Bourdon; Wissam Hamou; Noelle Dziedzic; Orit Goldman; Valerie Gouon-Evans
Journal:  J Stem Cell Res Ther       Date:  2012-08-15

2.  Activin, BMP and FGF pathways cooperate to promote endoderm and pancreatic lineage cell differentiation from human embryonic stem cells.

Authors:  Xiaofang Xu; Victoria L Browning; Jon S Odorico
Journal:  Mech Dev       Date:  2011-08-10       Impact factor: 1.882

3.  Modulation of activin A-induced differentiation in vitro by vascular endothelial growth factor in Xenopus presumptive ectodermal cells.

Authors:  Shiro Yoshida; Miho Furue; Kentaro Nagamine; Takanori Abe; Yasuto Fukui; Yasufumi Myoishi; Tomoyuki Fujii; Tetsuji Okamoto; Yuji Taketani; Makoto Asashima
Journal:  In Vitro Cell Dev Biol Anim       Date:  2005 Mar-Apr       Impact factor: 2.416

4.  Isolation and differentiation of chondrocytic cells derived from human embryonic stem cells using dlk1/FA1 as a novel surface marker.

Authors:  Linda Harkness; Hanna Taipaleenmaki; Amer Mahmood; Ulrik Frandsen; Anna-Marja Saamanen; Moustapha Kassem; Basem M Abdallah
Journal:  Stem Cell Rev Rep       Date:  2009-12       Impact factor: 5.739

5.  Generation of functional human pancreatic β cells in vitro.

Authors:  Felicia W Pagliuca; Jeffrey R Millman; Mads Gürtler; Michael Segel; Alana Van Dervort; Jennifer Hyoje Ryu; Quinn P Peterson; Dale Greiner; Douglas A Melton
Journal:  Cell       Date:  2014-10-09       Impact factor: 41.582

6.  The renaissance of developmental biology.

Authors:  Daniel St Johnston
Journal:  PLoS Biol       Date:  2015-05-06       Impact factor: 8.029

Review 7.  In Vitro organogenesis using amphibian pluripotent cells.

Authors:  Koji Okabayashi; Makoto Asashima
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2006-11-18       Impact factor: 3.493

Review 8.  Molecular specification of germ layers in vertebrate embryos.

Authors:  Clemens Kiecker; Thomas Bates; Esther Bell
Journal:  Cell Mol Life Sci       Date:  2015-12-14       Impact factor: 9.261

9.  Coco regulates dorsoventral specification of germ layers via inhibition of TGFβ signalling.

Authors:  Thomas J D Bates; Alin Vonica; Janet Heasman; Ali H Brivanlou; Esther Bell
Journal:  Development       Date:  2013-09-11       Impact factor: 6.868

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.